These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20946923)

  • 41. A mini review of nanosuspensions development.
    Liu Y; Xie P; Zhang D; Zhang Q
    J Drug Target; 2012 Apr; 20(3):209-23. PubMed ID: 22192053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
    Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
    Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability.
    Wang Y; Wang C; Zhao J; Ding Y; Li L
    J Colloid Interface Sci; 2017 Jan; 485():91-98. PubMed ID: 27657837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved stability and oral bioavailability of Ganneng dropping pills following transforming lignans of herpetospermum caudigerum into nanosuspensions.
    Li JJ; Cheng L; Shen G; Qiu L; Shen CY; Zheng J; Xu R; Yuan HL
    Chin J Nat Med; 2018 Jan; 16(1):70-80. PubMed ID: 29425592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
    Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term stability of quercetin nanocrystals prepared by different methods.
    Kakran M; Shegokar R; Sahoo NG; Gohla S; Li L; Müller RH
    J Pharm Pharmacol; 2012 Oct; 64(10):1394-402. PubMed ID: 22943170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
    Karakucuk A; Celebi N
    Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and characterization of amoxicillin nanostructures.
    Tian X; Fei J; Pi Z; Yang C; Luo D
    Nanomedicine; 2005 Dec; 1(4):323-5. PubMed ID: 17292106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
    Kocbek P; Baumgartner S; Kristl J
    Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stability studies of As4S4 nanosuspension prepared by wet milling in Poloxamer 407.
    Bujňáková Z; Dutková E; Baláž M; Turianicová E; Baláž P
    Int J Pharm; 2015 Jan; 478(1):187-192. PubMed ID: 25448581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
    Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
    Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
    Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
    Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of All-Trans Retinoic Acid nanosuspensions using a modified precipitation method.
    Zhang X; Xia Q; Gu N
    Drug Dev Ind Pharm; 2006 Aug; 32(7):857-63. PubMed ID: 16908423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery.
    Liu Y; Zhang D; Duan C; Jia L; Xie P; Zheng D; Wang F; Liu G; Hao L; Zhang X; Zhang Q
    J Microencapsul; 2012; 29(2):194-203. PubMed ID: 22172025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.